V019-3217 Screening compound: N-[4-(4-methoxyphenyl)-1-(4-methylphenyl)-1H-imidazol-2-yl]-2-[1-(2-methylphenyl)-N-[(oxolan-2-yl)methyl]formamido]acetamide

V019-3217 Screening compound: N-[4-(4-methoxyphenyl)-1-(4-methylphenyl)-1H-imidazol-2-yl]-2-[1-(2-methylphenyl)-N-[(oxolan-2-yl)methyl]formamido]acetamide
V019-3217 Screening compound: N-[4-(4-methoxyphenyl)-1-(4-methylphenyl)-1H-imidazol-2-yl]-2-[1-(2-methylphenyl)-N-[(oxolan-2-yl)methyl]formamido]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V019-3217
N-[4-(4-methoxyphenyl)-1-(4-methylphenyl)-1H-imidazol-2-yl]-2-[1-(2-methylphenyl)-N-[(oxolan-2-yl)methyl]formamido]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V019-3217

Molecular Formula

C32H34N4O4 (C32 H34 N4 O4)

Compound Name

N-[4-(4-methoxyphenyl)-1-(4-methylphenyl)-1H-imidazol-2-yl]-2-[1-(2-methylphenyl)-N-[(oxolan-2-yl)methyl]formamido]acetamide

IUPAC name

N-[4-(4-methoxyphenyl)-1-(4-methylphenyl)-1H-imidazol-2-yl]-2-[1-(2-methylphenyl)-N-[(oxolan-2-yl)methyl]formamido]acetamide

SMILES

Cc(cc1)ccc1-n1c(NC(CN(CC2OCCC2)C(c2c(C)cccc2)=O)=O)nc(-c(cc2)ccc2OC)c1

InChI

InChI=1S/C32H34N4O4/c1-22-10-14-25(15-11-22)36-20-29(24-12-16-26(39-3)17-13-24)33-32(36)34-30(37)21-35(19-27-8-6-18-40-27)31(38)28-9-5-4-7-23(28)2/h4-5,7,9-17,20,27H,6,8,18-19,21H2,1-3H3,(H,33,34,37)/t27-/m1/s1

InChI Key

MGCXVKVBETZPJY-HHHXNRCGSA-N

MDL Number (MFCD)

MFCD19832768

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

538.65

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

5.446

Distribution Coefficient, logD

5.446

Water Solubility, LogSw

-5.20

Polar Surface Area

68.591

Acid Dissociation Constant (pKa)

13.10

Base Dissociation Constant (pKb)

2.50

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

28.10

V019-3217 in Drug Discovery

Included in Screening Libraries

Regenerative Medicine Focused Library (23016 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with V019-3217 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V019-3217?
Check Price and Availability of V019-3217, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V019-3217 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V019-3217
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V019-3217
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V019-3217 available by request